Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Real-World check: how well does doravirine control HIV?

NCT ID NCT05421806

First seen Jan 07, 2026 · Last updated May 20, 2026 · Updated 20 times

Summary

This study tracks 500 people with HIV across Europe who are taking a drug called doravirine. Researchers want to see how well the drug controls the virus over 12 months, how often people stop taking it, and if the virus becomes resistant. The goal is to understand how doravirine works in everyday medical practice, not just in controlled trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bichat-Claude Bernard Hospital

    Paris, France

  • CHU Nantes University Hospital

    Nantes, France

  • CHU de Nantes

    Nantes, France

  • Chelsea and Westminster Hospital

    London, United Kingdom

  • Erasmus University Medical Center

    Rotterdam, Netherlands

  • Guy's Hospital

    London, United Kingdom

  • Hopital Universitaire Pitie-Salpetriere

    Paris, France

  • Hospital Center University De Montpellier

    Montpellier, France

  • Hospital Center University De Nice

    Nice, France

  • Hospital Clínic de Barcelona

    Barcelona, Spain

  • Hospital Saint Antoine

    Paris, France

  • Institute Of Tropical Medicine Antwerp

    Antwerp, Belgium

  • Lariboisière Hospital

    Paris, France

  • Mortimer Market Center, Central and North West London NHS Trust

    London, United Kingdom

  • Saint-Louis Hospital

    Paris, France

  • Saint-Pierre University Hospital

    Brussels, Belgium

  • Southmead Hospital

    Bristol, United Kingdom

  • St Louis Hospital

    Paris, France

  • University Hospitals Pitié Salpêtrière

    Paris, France

Conditions

Explore the condition pages connected to this study.